Glenmark gets tentative USFDA approval for generic anti-diabetes tablets
The approval is for the strength of 10 mg/5 mg tablets
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Kiran Mazumdar-Shaw Recognized among World’s Top 20 Inspirational Leaders in Biopharmaceuticals in…
The Medicine Maker ‘Power List 20 for 2020’ celebrates 60 great minds who have brought the world innovation in small molecules,…
Strides develops and commences export of Favipiravir Antiviral Tablets
The product is currently being exported to GCC countries to treat patients under their treatment program for COVID-19
Need border passes, worker passes: Ashesh Ghosh, Rolls Pack
Ashesh Ghosh, CEO, Rolls Pack says that more planning and border passes for vehicles and personnel will be required to ensure the…
India’s pharma capabilities would remain available to the world: PM Modi
This message was part of his telephone conversation with Justin Trudeau, Prime Minister of Canada
PharmaLytica 2020 gets postponed to September in light of COVID-19 threat
The event, originally scheduled for June 10-12, 2020 at Bombay Exhibition Center, Mumbai, will be held from September 9-11, 2020…
Sheffield joins national PRINCIPLE trial
The trial aims to see if drugs already available, like hydroxychloroquine, can help prevent older people becoming more seriously…
AYUSH Ministry initiates efforts to bring Indian traditional medicines under D&C Act 1940
A notification informs that scientists, researchers, clinicians can carry out research on COVID-19 through Ayurveda, Homeopathy…
Biocon and Mylan launch fulphila — biosimilar to pegfilgrastim, in Canada
The approval of fulphila was based on a comprehensive package of analytical, non-clinical and clinical data, which confirmed that…
Marinomed receives FFG funding to research SARS-CoV-2 therapy based on carragelose
Available clinical data show that Carragelose binds previously known coronaviruses and other viruses that trigger respiratory…